CompoAtlas

Gastroval® FLUXUS (2022.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000069/2022
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
Valentis Baltic UAB
Manufacturer
name not reproduced (no recognised company form)
Origin
Latvija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
2 kapsulas dienā
Published pack size
kapsulas pa 640 mg
Published packaging
15 kapsulas

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
Magnijsminerals ; Magnijs ; 200 ; mgMagnésiumVitamin or mineral
Dzeltenā genciānaplants ; Dzeltenā genciāna ; Gentiana lutea ; ekstrakts ; 60 ; mggentiana luteaPlant
Ingversplants ; Ingvers ; Zingiber officinale ; ekstrakts ; 52 ; mgzingiber officinalePlant
Fenhelisplants ; Fenhelis ; Foeniculum vulgare ; ekstrakts ; 50 ; mgfoeniculum vulgarePlant
Grieķu sierāboliņšplants ; Grieķu sierāboliņš ; Trigonella foenum-graecum ; ekstrakts ; 50 ; mgtrigonella foenum-graecumPlant
Saflorveidīgā leizejaplants ; Saflorveidīgā leizeja ; Rhaponticum carthamoides ; ekstrakts ; 25 ; mgrhaponticum carthamoidesPlant
Lakricaplants ; Lakrica ; Glycyrrhiza glabra ; ekstrakts ; 21 ; mgglycyrrhiza glabraPlant
Deglicirizinēts lakricas (Glycyrrhiza glabra) (DGL) sakņu sausais ekstrakts (4:1)otherNutrients ; Deglicirizinēts lakricas (Glycyrrhiza glabra) (DGL) sakņu sausais ekstrakts (4:1) ; 240 ; mgNot recognisedRole not identified
Inulīns otherNutrients ; Inulīns ; 100 ; mgNot recognisedRole not identified
Natenzym® D (7 enzīmu maisījums, kas satur amilāzi, celulāzi, laktāzi, proteāzi, pektināzi, glikoamilāzi, lipāzi)otherNutrients ; Natenzym® D (7 enzīmu maisījums, kas satur amilāzi, celulāzi, laktāzi, proteāzi, pektināzi, glikoamilāzi, lipāzi) ; 75 ; mgNot recognisedRole not identified
Lactobacillus acidophilus 11 mgotherNutrients ; Lactobacillus acidophilus 11 mg ; 10x10 (9) ; KVVLactobacillus AcidophilusRole not identified
Bifidobacterium bifidum 3.7 mgotherNutrients ; Bifidobacterium bifidum 3.7 mg ; 10x10 (9) ; KVVBifidobacterium BifidumRole not identified
MaltodekstrīnsotherIngredients ; Maltodekstrīns ; - ; gNot recognisedRole not identified
199foodAdditives ; 199Not recognisedRole not identified
205foodAdditives ; 205Not recognisedRole not identified
258foodAdditives ; 258Not recognisedRole not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Ražots Eiropas Savienībā

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Dzeltenā genciāna
    Read the warning, when it applies and the studies cited

    Gentian - Gentiana Lutea

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Contraindications

    Do not use if you are pregnant (Hoffmann 2003; Morimoto et al.1983).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have stomach or duodenal acute inflammation or ulcer (Brinker 2010; ESCOP 2003; Bradley 1992).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    When using this product you may experience headaches (ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 10 January 2025

  • Ingvers
    Read the warning, when it applies and the studies cited

    GINGER - ZINGIBER OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 19 December 2025

  • Fenhelis
    Read the warning, when it applies and the studies cited

    BITTER FENNEL- FOENICULUM VULGARE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024, 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Essential oil and Tincture.

    Ask a health care practitioner before use if you are taking any medications including birth control pills or hormone therapy or other health products (EMA 2007).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (EMA 2024, 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

    SWEET FENNEL -FOENICULUM VULGARE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (EMA 2024).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

  • Grieķu sierāboliņš
    Read the warning, when it applies and the studies cited

    FENUGREEK - TRIGONELLA FOENUM-GRAECUM - Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Gardner and McGuffin 2013; Brinker 2010; Mills et al. 2006; Hoffman 2003; Blumenthal et al. 2000).

    5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Mills and Bone 2005).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 May 2026

    FENUGREEK - TRIGONELLA FOENUM-GRAECUM - Topical

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 29 May 2026

  • Lakrica
    Read the warning, when it applies and the studies cited

    DEGLYCYRRHIZINATED LICORICE Buccal

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 October 2025

    Deglycyrrhizinated Licorice Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 January 2025

    LICORICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Cough relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Gastritis relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant (EMA 2012).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line